Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences to Peer Perform from Outperform with a "fair value" range for the stock at $65-$85.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EW:
Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences to Peer Perform from Outperform with a "fair value" range for the stock at $65-$85.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EW: